Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia

References

• Weatherall DJ . The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev . 2012;26(Suppl 1):S3–S6. doi:10.1016/S0268-960X(12)70003-6 22631040
   PubMed Web of Science ®Google Scholar
• De Sanctis V , Kattamis C , Canatan D , et al. beta-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis . 2017;9(1):e2017018. doi:10.4084/mjhid.2017.018 28293406
   PubMed Web of Science ®Google Scholar
• Lai K , Huang G , Su L , He Y . The prevalence of thalassemia in mainland China: evidence from epidemiological surveys. Sci Rep . 2017;7(1):920. doi:10.1038/s41598-017-00967-2 28424478
   PubMed Web of Science ®Google Scholar
• Baldini M , Marcon A , Cassin R , et al. Beta-thalassaemia intermedia: evaluation of endocrine and bone complications. Biomed Res Int . 2014;2014:174581. doi:10.1155/2014/174581 25110660
   PubMed Web of Science ®Google Scholar
• Inati A , Noureldine MA , Mansour A , Abbas HA . Endocrine and bone complications in beta-thalassemia intermedia: current understanding and treatment. Biomed Res Int . 2015;2015:813098.25834825
   PubMed Web of Science ®Google Scholar
• De Sanctis V , Soliman AT , Elsedfy H , et al. Diabetes and glucose metabolism in thalassemia major: an update. Expert Rev Hematol . 2016;9(4):401–408.26697756
   PubMed Web of Science ®Google Scholar
• Tzoulis P , Shah F , Jones R , Prescott E , Barnard M . Joint diabetes thalassaemia clinic: an effective new model of care. Hemoglobin . 2014;38(2):104–110.24351096
   PubMed Web of Science ®Google Scholar
• Liang Y , Bajoria R , Jiang Y , et al. Prevalence of diabetes mellitus in Chinese children with thalassaemia major. Trop Med Int Health . 2017;22(6):716–724.28544032
   PubMed Web of Science ®Google Scholar
• Alberti KG , Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med . 1998;15(7):539–553.9686693
   PubMed Web of Science ®Google Scholar
• Huang Z , Liu J , Ma L , et al. Glucose metabolism, insulin sensitivity and beta-cell function in type A insulin resistance syndrome around puberty: a 9-year follow-up. Horm Metab Res . 2014;46(1):65–72. doi:10.1055/s-0033-1357193 24155250
   PubMed Web of Science ®Google Scholar
• Matthews DR , Hosker JP , Rudenski AS , Naylor BA , Treacher DF , Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia . 1985;28(7):412–419.3899825
   PubMed Web of Science ®Google Scholar
• Taher A , Vichinsky E , Musallam K , et al.  Iron overload and chelation therapy, Chap.5. In: Weatherall D, editor. Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT)  [Internet]. Nicosia, Cyprus: Thalassaemia International Federation; 2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK190440/
   Google Scholar
• De Sanctis V , Soliman A , Yassin M . Iron overload and glucose metabolism in subjects with beta-thalassaemia major: an overview. Curr Diabetes Rev . 2013;9(4):332–341.23687960
   PubMedGoogle Scholar
• Cario H , Holl RW , Debatin KM , Kohne E . Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr . 2003;162(3):139–146. doi:10.1007/s00431-002-1121-7 12655415
   PubMed Web of Science ®Google Scholar
• Ly L , Wq L , Meng Z , et al. Analysis of the influence of iron overload in glucose metabolism in thalassemia major patients. Zhonghua Er Ke Za Zhi . 2017;55(6):419–422. doi:10.3760/cma.j.issn.0578-1310.2017.06.005 28592008
   PubMedGoogle Scholar
• Luo HC , Luo QS , Huang FG , Wang CF , Wei YS . Impact of genotype on endocrinal complications of children with alpha-thalassemia in China. Sci Rep . 2017;7(1):2948. doi:10.1038/s41598-017-03029-9 28592815
   PubMed Web of Science ®Google Scholar
• Taher AT , Musallam KM , Karimi M , et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood . 2010;115(10):1886–1892. doi:10.1182/blood-2009-09-243154 20032507
   PubMed Web of Science ®Google Scholar
• Chatterjee R , Bajoria R . New concept in natural history and management of diabetes mellitus in thalassemia major. Hemoglobin . 2009;33(Suppl 1):S127–S130. doi:10.3109/09553000903347880 20001615
   PubMedGoogle Scholar
• Ghergherehchi R , Habibzadeh A . Insulin resistance and beta cell function in patients with beta-thalassemia major. Hemoglobin . 2015;39(1):69–73. doi:10.3109/03630269.2014.999081 25572183
   PubMed Web of Science ®Google Scholar
• Tangvarasittichai S , Pimanprom A , Choowet A , Tangvarasittichai O . Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients. Clin Lab . 2013;59(7–8):861–868.24133917
   PubMed Web of Science ®Google Scholar
• de Assis RA , Ribeiro AA , Kay FU , et al. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients. Eur J Radiol . 2012;81(7):1465–1470. doi:10.1016/j.ejrad.2011.03.077 21501938
   PubMed Web of Science ®Google Scholar
• Okita K , Iwahashi H , Kozawa J , et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J . 2013;60(3):283–290.23149658
   PubMed Web of Science ®Google Scholar
• Shirley M , Plosker GL . Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia. Drugs . 2014;74(9):1017–1027. doi:10.1007/s40265-014-0238-0 24919862
   PubMed Web of Science ®Google Scholar
• Taher AT , Viprakasit V , Musallam KM , Cappellini MD . Treating iron overload in patients with non-transfusion-dependent thalassemia. Am J Hematol . 2013;88(5):409–415. doi:10.1002/ajh.23405 23475638
   PubMed Web of Science ®Google Scholar
• Vichinsky E , Cohen A , Thompson AA , et al. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States. Pediatr Blood Cancer . 2018;65(7):e27067. doi:10.1002/pbc.27067 29637688
   PubMed Web of Science ®Google Scholar
• Musallam KM , Cappellini MD , Wood JC , Taher AT . Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev . 2012;26(Suppl 1):S16–S19. doi:10.1016/S0268-960X(12)70006-1 22631036
   PubMed Web of Science ®Google Scholar
• Ambachew S , Biadgo B . Hepcidin in iron homeostasis: diagnostic and therapeutic implications in type 2 diabetes mellitus patients. Acta Haematol . 2017;138(4):183–193. doi:10.1159/000481391 29136618
   PubMed Web of Science ®Google Scholar
• Nakavachara P , Viprakasit V . Adrenal insufficiency is prevalent in HbE/beta-thalassaemia paediatric patients irrespective of their clinical severity and transfusion requirement. Clin Endocrinol (Oxf) . 2013;79(6):776–783. doi:10.1111/cen.12235 23634994
   PubMed Web of Science ®Google Scholar
• Nakavachara P , Petchkul J , Jeerawongpanich K , et al. Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/beta-thalassemia and its relationship with anemia severity. Pediatr Blood Cancer . 2018;65:1. doi:10.1002/pbc.26744
   Web of Science ®Google Scholar
• Baldini M , Marcon A , Ulivieri FM , et al. Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables. Ann Hematol . 2017;96(6):995–1003. doi:10.1007/s00277-017-2959-0 28321531
   PubMed Web of Science ®Google Scholar
• Tantiworawit A , Charoenkwan P , Hantrakool S , Choeyprasert W , Sivasomboon C , Sanguansermsri T . Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors. Int J Hematol . 2016;103(6):643–648. doi:10.1007/s12185-016-1991-5 27052211
   PubMed Web of Science ®Google Scholar
• Frazer DM , Wilkins SJ , Mirciov CS , Dunn LA , Anderson GJ . Hepcidin independent iron recycling in a mouse model of beta-thalassaemia intermedia. Br J Haematol . 2016;175(2):308–317. doi:10.1111/bjh.14206 27410488
   PubMed Web of Science ®Google Scholar
• Musallam KM , Cappellini MD , Taher AT . Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia. Blood Cells Mol Dis . 2013;51(1):35–38. doi:10.1016/j.bcmd.2013.01.015 23425967
   PubMed Web of Science ®Google Scholar
• Acton RT , Barton JC , Passmore LV , et al. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Diabetes Care . 2006;29(9):2084–2089. doi:10.2337/dc05-1592 16936157
   PubMed Web of Science ®Google Scholar
• Chern JP , Lin KH , Lu MY , et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care . 2001;24(5):850–854.11347742
   PubMed Web of Science ®Google Scholar
• Karimi M , Amirmoezi F , Haghpanah S , et al. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: a contemporary issue. Pediatr Hematol Oncol . 2017;34(5):292–297. doi:10.1080/08880018.2017.1400135 29190176
   PubMed Web of Science ®Google Scholar
• Asadov C , Alimirzoeva Z , Mammadova T , Aliyeva G , Gafarova S , Mammadov J . beta-Thalassemia intermedia: a comprehensive overview and novel approaches. Int J Hematol . 2018;108(1):5–21. doi:10.1007/s12185-018-2411-9 29380178
   PubMed Web of Science ®Google Scholar
• Vichinsky E . Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin . 2016;32(1):191–204. doi:10.1185/03007995.2015.1110128 26479125
   PubMed Web of Science ®Google Scholar